Genital Herpes Treatment Drugs Market - Global Outlook and Forecast 2023-2028

Report ID: 1566582 | Published Date: Jan 2025 | No. of Page: 63 | Base Year: 2024 | Rating: 3.9 | Webstory: Check our Web story
1 Introduction to Research & Analysis Reports
    1.1 Genital Herpes Treatment Drugs Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Genital Herpes Treatment Drugs Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Genital Herpes Treatment Drugs Overall Market Size
    2.1 Global Genital Herpes Treatment Drugs Market Size: 2021 VS 2028
    2.2 Global Genital Herpes Treatment Drugs Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Genital Herpes Treatment Drugs Players in Global Market
    3.2 Top Global Genital Herpes Treatment Drugs Companies Ranked by Revenue
    3.3 Global Genital Herpes Treatment Drugs Revenue by Companies
    3.4 Top 3 and Top 5 Genital Herpes Treatment Drugs Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Genital Herpes Treatment Drugs Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Genital Herpes Treatment Drugs Players in Global Market
        3.6.1 List of Global Tier 1 Genital Herpes Treatment Drugs Companies
        3.6.2 List of Global Tier 2 and Tier 3 Genital Herpes Treatment Drugs Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Genital Herpes Treatment Drugs Market Size Markets, 2021 & 2028
        4.1.2 Acyclovir
        4.1.3 Famciclovir
        4.1.4 Valacyclovir
    4.2 By Type - Global Genital Herpes Treatment Drugs Revenue & Forecasts
        4.2.1 By Type - Global Genital Herpes Treatment Drugs Revenue, 2017-2022
        4.2.2 By Type - Global Genital Herpes Treatment Drugs Revenue, 2023-2028
        4.2.3 By Type - Global Genital Herpes Treatment Drugs Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Genital Herpes Treatment Drugs Market Size, 2021 & 2028
        5.1.2 Hospitals
        5.1.3 Clinic
        5.1.4 Others
    5.2 By Application - Global Genital Herpes Treatment Drugs Revenue & Forecasts
        5.2.1 By Application - Global Genital Herpes Treatment Drugs Revenue, 2017-2022
        5.2.2 By Application - Global Genital Herpes Treatment Drugs Revenue, 2023-2028
        5.2.3 By Application - Global Genital Herpes Treatment Drugs Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Genital Herpes Treatment Drugs Market Size, 2021 & 2028
    6.2 By Region - Global Genital Herpes Treatment Drugs Revenue & Forecasts
        6.2.1 By Region - Global Genital Herpes Treatment Drugs Revenue, 2017-2022
        6.2.2 By Region - Global Genital Herpes Treatment Drugs Revenue, 2023-2028
        6.2.3 By Region - Global Genital Herpes Treatment Drugs Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Genital Herpes Treatment Drugs Revenue, 2017-2028
        6.3.2 US Genital Herpes Treatment Drugs Market Size, 2017-2028
        6.3.3 Canada Genital Herpes Treatment Drugs Market Size, 2017-2028
        6.3.4 Mexico Genital Herpes Treatment Drugs Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Genital Herpes Treatment Drugs Revenue, 2017-2028
        6.4.2 Germany Genital Herpes Treatment Drugs Market Size, 2017-2028
        6.4.3 France Genital Herpes Treatment Drugs Market Size, 2017-2028
        6.4.4 U.K. Genital Herpes Treatment Drugs Market Size, 2017-2028
        6.4.5 Italy Genital Herpes Treatment Drugs Market Size, 2017-2028
        6.4.6 Russia Genital Herpes Treatment Drugs Market Size, 2017-2028
        6.4.7 Nordic Countries Genital Herpes Treatment Drugs Market Size, 2017-2028
        6.4.8 Benelux Genital Herpes Treatment Drugs Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Genital Herpes Treatment Drugs Revenue, 2017-2028
        6.5.2 China Genital Herpes Treatment Drugs Market Size, 2017-2028
        6.5.3 Japan Genital Herpes Treatment Drugs Market Size, 2017-2028
        6.5.4 South Korea Genital Herpes Treatment Drugs Market Size, 2017-2028
        6.5.5 Southeast Asia Genital Herpes Treatment Drugs Market Size, 2017-2028
        6.5.6 India Genital Herpes Treatment Drugs Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Genital Herpes Treatment Drugs Revenue, 2017-2028
        6.6.2 Brazil Genital Herpes Treatment Drugs Market Size, 2017-2028
        6.6.3 Argentina Genital Herpes Treatment Drugs Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Genital Herpes Treatment Drugs Revenue, 2017-2028
        6.7.2 Turkey Genital Herpes Treatment Drugs Market Size, 2017-2028
        6.7.3 Israel Genital Herpes Treatment Drugs Market Size, 2017-2028
        6.7.4 Saudi Arabia Genital Herpes Treatment Drugs Market Size, 2017-2028
        6.7.5 UAE Genital Herpes Treatment Drugs Market Size, 2017-2028
7 Players Profiles
    7.1 AstraZeneca, Plc.
        7.1.1 AstraZeneca, Plc. Corporate Summary
        7.1.2 AstraZeneca, Plc. Business Overview
        7.1.3 AstraZeneca, Plc. Genital Herpes Treatment Drugs Major Product Offerings
        7.1.4 AstraZeneca, Plc. Genital Herpes Treatment Drugs Revenue in Global Market (2017-2022)
        7.1.5 AstraZeneca, Plc. Key News
    7.2 Apotheca, Inc.
        7.2.1 Apotheca, Inc. Corporate Summary
        7.2.2 Apotheca, Inc. Business Overview
        7.2.3 Apotheca, Inc. Genital Herpes Treatment Drugs Major Product Offerings
        7.2.4 Apotheca, Inc. Genital Herpes Treatment Drugs Revenue in Global Market (2017-2022)
        7.2.5 Apotheca, Inc. Key News
    7.3 Asahi Kasei Pharma Corporation
        7.3.1 Asahi Kasei Pharma Corporation Corporate Summary
        7.3.2 Asahi Kasei Pharma Corporation Business Overview
        7.3.3 Asahi Kasei Pharma Corporation Genital Herpes Treatment Drugs Major Product Offerings
        7.3.4 Asahi Kasei Pharma Corporation Genital Herpes Treatment Drugs Revenue in Global Market (2017-2022)
        7.3.5 Asahi Kasei Pharma Corporation Key News
    7.4 Carlsbad Technology, Inc.
        7.4.1 Carlsbad Technology, Inc. Corporate Summary
        7.4.2 Carlsbad Technology, Inc. Business Overview
        7.4.3 Carlsbad Technology, Inc. Genital Herpes Treatment Drugs Major Product Offerings
        7.4.4 Carlsbad Technology, Inc. Genital Herpes Treatment Drugs Revenue in Global Market (2017-2022)
        7.4.5 Carlsbad Technology, Inc. Key News
    7.5 GlaxoSmithkline, Plc.
        7.5.1 GlaxoSmithkline, Plc. Corporate Summary
        7.5.2 GlaxoSmithkline, Plc. Business Overview
        7.5.3 GlaxoSmithkline, Plc. Genital Herpes Treatment Drugs Major Product Offerings
        7.5.4 GlaxoSmithkline, Plc. Genital Herpes Treatment Drugs Revenue in Global Market (2017-2022)
        7.5.5 GlaxoSmithkline, Plc. Key News
    7.6 Mylan N.V.
        7.6.1 Mylan N.V. Corporate Summary
        7.6.2 Mylan N.V. Business Overview
        7.6.3 Mylan N.V. Genital Herpes Treatment Drugs Major Product Offerings
        7.6.4 Mylan N.V. Genital Herpes Treatment Drugs Revenue in Global Market (2017-2022)
        7.6.5 Mylan N.V. Key News
    7.7 Novartis AG.
        7.7.1 Novartis AG. Corporate Summary
        7.7.2 Novartis AG. Business Overview
        7.7.3 Novartis AG. Genital Herpes Treatment Drugs Major Product Offerings
        7.7.4 Novartis AG. Genital Herpes Treatment Drugs Revenue in Global Market (2017-2022)
        7.7.5 Novartis AG. Key News
    7.8 Merck & Co., Inc.
        7.8.1 Merck & Co., Inc. Corporate Summary
        7.8.2 Merck & Co., Inc. Business Overview
        7.8.3 Merck & Co., Inc. Genital Herpes Treatment Drugs Major Product Offerings
        7.8.4 Merck & Co., Inc. Genital Herpes Treatment Drugs Revenue in Global Market (2017-2022)
        7.8.5 Merck & Co., Inc. Key News
    7.9 Teva Pharmaceutical Industries Ltd.
        7.9.1 Teva Pharmaceutical Industries Ltd. Corporate Summary
        7.9.2 Teva Pharmaceutical Industries Ltd. Business Overview
        7.9.3 Teva Pharmaceutical Industries Ltd. Genital Herpes Treatment Drugs Major Product Offerings
        7.9.4 Teva Pharmaceutical Industries Ltd. Genital Herpes Treatment Drugs Revenue in Global Market (2017-2022)
        7.9.5 Teva Pharmaceutical Industries Ltd. Key News
    7.10 Zydus Pharmaceuticals, Inc.
        7.10.1 Zydus Pharmaceuticals, Inc. Corporate Summary
        7.10.2 Zydus Pharmaceuticals, Inc. Business Overview
        7.10.3 Zydus Pharmaceuticals, Inc. Genital Herpes Treatment Drugs Major Product Offerings
        7.10.4 Zydus Pharmaceuticals, Inc. Genital Herpes Treatment Drugs Revenue in Global Market (2017-2022)
        7.10.5 Zydus Pharmaceuticals, Inc. Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer
List of Tables
    Table 1. Genital Herpes Treatment Drugs Market Opportunities & Trends in Global Market
    Table 2. Genital Herpes Treatment Drugs Market Drivers in Global Market
    Table 3. Genital Herpes Treatment Drugs Market Restraints in Global Market
    Table 4. Key Players of Genital Herpes Treatment Drugs in Global Market
    Table 5. Top Genital Herpes Treatment Drugs Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Genital Herpes Treatment Drugs Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Genital Herpes Treatment Drugs Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Genital Herpes Treatment Drugs Product Type
    Table 9. List of Global Tier 1 Genital Herpes Treatment Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Genital Herpes Treatment Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Genital Herpes Treatment Drugs Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Genital Herpes Treatment Drugs Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Genital Herpes Treatment Drugs Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Genital Herpes Treatment Drugs Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Genital Herpes Treatment Drugs Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Genital Herpes Treatment Drugs Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2023-2028
    Table 30. AstraZeneca, Plc. Corporate Summary
    Table 31. AstraZeneca, Plc. Genital Herpes Treatment Drugs Product Offerings
    Table 32. AstraZeneca, Plc. Genital Herpes Treatment Drugs Revenue (US$, Mn), (2017-2022)
    Table 33. Apotheca, Inc. Corporate Summary
    Table 34. Apotheca, Inc. Genital Herpes Treatment Drugs Product Offerings
    Table 35. Apotheca, Inc. Genital Herpes Treatment Drugs Revenue (US$, Mn), (2017-2022)
    Table 36. Asahi Kasei Pharma Corporation Corporate Summary
    Table 37. Asahi Kasei Pharma Corporation Genital Herpes Treatment Drugs Product Offerings
    Table 38. Asahi Kasei Pharma Corporation Genital Herpes Treatment Drugs Revenue (US$, Mn), (2017-2022)
    Table 39. Carlsbad Technology, Inc. Corporate Summary
    Table 40. Carlsbad Technology, Inc. Genital Herpes Treatment Drugs Product Offerings
    Table 41. Carlsbad Technology, Inc. Genital Herpes Treatment Drugs Revenue (US$, Mn), (2017-2022)
    Table 42. GlaxoSmithkline, Plc. Corporate Summary
    Table 43. GlaxoSmithkline, Plc. Genital Herpes Treatment Drugs Product Offerings
    Table 44. GlaxoSmithkline, Plc. Genital Herpes Treatment Drugs Revenue (US$, Mn), (2017-2022)
    Table 45. Mylan N.V. Corporate Summary
    Table 46. Mylan N.V. Genital Herpes Treatment Drugs Product Offerings
    Table 47. Mylan N.V. Genital Herpes Treatment Drugs Revenue (US$, Mn), (2017-2022)
    Table 48. Novartis AG. Corporate Summary
    Table 49. Novartis AG. Genital Herpes Treatment Drugs Product Offerings
    Table 50. Novartis AG. Genital Herpes Treatment Drugs Revenue (US$, Mn), (2017-2022)
    Table 51. Merck & Co., Inc. Corporate Summary
    Table 52. Merck & Co., Inc. Genital Herpes Treatment Drugs Product Offerings
    Table 53. Merck & Co., Inc. Genital Herpes Treatment Drugs Revenue (US$, Mn), (2017-2022)
    Table 54. Teva Pharmaceutical Industries Ltd. Corporate Summary
    Table 55. Teva Pharmaceutical Industries Ltd. Genital Herpes Treatment Drugs Product Offerings
    Table 56. Teva Pharmaceutical Industries Ltd. Genital Herpes Treatment Drugs Revenue (US$, Mn), (2017-2022)
    Table 57. Zydus Pharmaceuticals, Inc. Corporate Summary
    Table 58. Zydus Pharmaceuticals, Inc. Genital Herpes Treatment Drugs Product Offerings
    Table 59. Zydus Pharmaceuticals, Inc. Genital Herpes Treatment Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Genital Herpes Treatment Drugs Segment by Type in 2021
    Figure 2. Genital Herpes Treatment Drugs Segment by Application in 2021
    Figure 3. Global Genital Herpes Treatment Drugs Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Genital Herpes Treatment Drugs Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Genital Herpes Treatment Drugs Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Genital Herpes Treatment Drugs Revenue in 2021
    Figure 8. By Type - Global Genital Herpes Treatment Drugs Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Genital Herpes Treatment Drugs Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Genital Herpes Treatment Drugs Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Genital Herpes Treatment Drugs Revenue Market Share, 2017-2028
    Figure 12. US Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Genital Herpes Treatment Drugs Revenue Market Share, 2017-2028
    Figure 16. Germany Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2028
    Figure 17. France Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Genital Herpes Treatment Drugs Revenue Market Share, 2017-2028
    Figure 24. China Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2028
    Figure 28. India Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Genital Herpes Treatment Drugs Revenue Market Share, 2017-2028
    Figure 30. Brazil Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Genital Herpes Treatment Drugs Revenue Market Share, 2017-2028
    Figure 33. Turkey Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2017-2028
    Figure 37. AstraZeneca, Plc. Genital Herpes Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Apotheca, Inc. Genital Herpes Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Asahi Kasei Pharma Corporation Genital Herpes Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Carlsbad Technology, Inc. Genital Herpes Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. GlaxoSmithkline, Plc. Genital Herpes Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Mylan N.V. Genital Herpes Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Novartis AG. Genital Herpes Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Merck & Co., Inc. Genital Herpes Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Teva Pharmaceutical Industries Ltd. Genital Herpes Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Zydus Pharmaceuticals, Inc. Genital Herpes Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
63
Frequently Asked Questions
Genital Herpes Treatment Drugs Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Genital Herpes Treatment Drugs Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Genital Herpes Treatment Drugs Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Retinol Market

Retinol, also known as Vitamin A1, is a vitamin found in food and used as a dietary supplement.&# ... Read More

Coenzyme A Market

Coenzyme A (CoA, SCoA, CoASH) is a coenzyme, notable for its role in the synthesis and oxidation  ... Read More